The recall is specific to Eliquis 5mg Tablets (60-count bottle) Lot# HN0063 with expiration date of September 2019. The two tablet strengths have distinct differences in appearance, which may ...

Results showed that Eliquis 10mg twice daily for one week followed by 5mg twice daily for six months showed effiacy comparable to standard of care in treating DVT/PE patients for the primary ...

Available in 2.5 mg and 5mg tablets, the product comes in multiple package sizes including 60, 180 and 500 btl. [Read more: Apotex launches generic atropine sulfate ophthalmic solution ] ...

The U.S. government on Tuesday selected the first 10 drugs, including the big-selling blood thinner Eliquis from Bristol Myers Squibb and Pfizer , that will be subject to the first-ever Medicare ...

Bristol-Myers said on Tuesday that it is voluntarily recalling to the customer level one lot of its Eliquis 5-mg tablets after a patient reported getting a bottle that contained 2.5-mg tablets.

Finasteride comes in 1mg or 5mg tablets. For male pattern baldness, stick to the 1mg dose daily, or follow a healthcare professional’s advice. Here’s a recap of what to know about 5mg ...

TORONTO — Canadian pharmaceutical manufacturer of generic medicines, Apotex Inc. has launched APO-ApixabanTM tablets and has called it the country’s first generic alternative to Eliquis®.

“Both the 2.5mg twice-daily regimen of apixaban and the 5mg twice-daily regimen were effective, safe, and simple to use,” they added. Eliquis recently had its indications extended to include the ...

Senores Pharmaceuticals, through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA, has signed agreement to acquire the US FDA-approved Abbreviated New Drug Application (ANDA) for ...

Roche’s Evrysdi (risdiplam) tablets have been approved by the European Commission (EC) to treat spinal muscular atrophy (SMA). The new, room-temperature stable formulation of Evrysdi may offer ...

PRINCETON, N.J., Dec. 31 /PRNewswire/ -- Ranbaxy Laboratories Limited (RLL), announced today that the company has received final approval from the U.S. Food and Drug Administration to manufacture and ...

CHADDS FORD, Pa., Nov. 2, 2011 /PRNewswire/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced that the U.S. Food and Drug Administration has approved Felodipine Extended-release Tablets USP ...